How long does it take for drug resistance to develop after using caposetinib/caposetinib?

Capivasertib Tablets/Capivasertib (Capivasertib) is an AKT inhibitor. Its mechanism of action is mainly by inhibiting the PI3K/AKT/mTOR signaling pathway, thereby blocking tumor cell proliferation and survival mechanisms. However, tumors are extremely adaptable to the development of targeted drugs, and the emergence of drug resistance is almost inevitable. There is no fixed standard answer to the resistance time of capositinib, as it is closely related to the patient's genetic mutation background, combination therapy regimen, medication compliance, etc. Based on overseas experience, it is generally believed that varying degrees of drug resistance may occur between 6 and 12 months after the use of capositinib.

The mechanisms of drug resistance are complex and diverse, including activation of downstream pathways (such as mTOR signal persistence), AKT mutation, changes in the tumor microenvironment, etc. Clinically, when a patient's tumor markers increase again during treatment, imaging shows enlarging lesions, or new metastases occur, the possibility of drug resistance needs to be considered. It is worth noting that capositinib is often used in combination with tamoxifen, fulvestrant and other drugs. Combination therapy can delay the occurrence of drug resistance to a certain extent, but once drug resistance occurs, its efficacy declines rapidly.

From a practical perspective, although there are individual differences in the time when drug resistance appears, early detection methods (such asctDNA monitoring, circulating tumor cell analysis) can help doctors identify drug resistance tendencies in advance and adjust treatment strategies. In addition, there are studies exploring second-generation AKT inhibitors and improved dual-target drugs to overcome the resistance problem. Therefore, when patients are using caposetinib to treat breast cancer, they should be closely followed up and dynamically evaluated for efficacy under the guidance of doctors. Once signs of resistance appear, the treatment plan should be changed in time to ensure long-term survival benefits.

Reference materials:https://www.drugs.com/mtm/capivasertib.html